Results 21 to 30 of about 695,872 (210)
Chronic shoulder pain referred from thymic carcinoma: a case report and review of literature
Shu-Wei Dee,1 Mu-Jung Kao,2,3 Chang-Zern Hong,4 Li-Wei Chou,1,5 Henry L Lew6,71Department of Physical Medicine and Rehabilitation, China Medical University Hospital, Taichung, 2Department of Physical Medicine and Rehabilitation, Yangming Branch, Taipei ...
Dee SW, Kao MJ, Hong CZ, Chou LW, Lew HL
doaj +1 more source
Efficacy and Safety of Lucitanib in Advanced Thymic Carcinoma: A Randomized Phase II Trial. [PDF]
In this randomized phase II trial, 68 patients with advanced thymic carcinoma after chemotherapy received lucitanib (n = 46) or placebo (n = 22). Median PFS was 5.8 versus 3.7 months by IRC (HR: 0.60; p = 0.105) and 6.6 versus 1.9 months by investigators (HR: 0.53; p = 0.031). Hypertension was the most common grade 3 TRAE (50%).
Fang W +21 more
europepmc +2 more sources
Well-differentiated thymic carcinoma: Is it thymic carcinoma or not? [PDF]
1and well-differentiated thymic carcinoma. 2 Our Nagoya City University series of thymic carcinoma consisted of 19 patients treated in 1980 through 1995. Inasmuch as there were 62 thymomas and 3 thymic carcinoids in the same period, the incidence of thymic carcinoma was 22.6% in thymic epithelial tumors.
Masaoka, Akira +2 more
openaire +4 more sources
Does myasthenia gravis affect long-term survival in thymic carcinomas? An ESTS database analysis [PDF]
: Background: Thymic carcinoma is a rare and highly malignant tumor with a dismal prognosis, which occasionally coexists with myasthenia gravis (MG). This study aims to investigate the MG incidence on a surgical cohort of patients with thymic carcinoma ...
Luca Voltolini +56 more
core +3 more sources
Background: B3 type thymoma is defined as a well-differentiated thymic carcinoma and is similar to a thymic carcinoma. However, the differences between them are not well defined.
Yue Hao +6 more
doaj +1 more source
The role of surgery in advanced thymic tumors: A retrospective cohort study
BackgroundThere is no definitive and detailed treatment guideline for advanced thymic tumors, thus when lymph node and other organ metastasis are present, clinical guidelines recommend chemotherapy-based multidisciplinary treatment.
Weifeng Qi, Hui Tian
doaj +1 more source
Thymoma and thymic carcinomas [PDF]
Thymomas (Ts) and thymic carcinomas (TCs) are rare tumours of the mediastinum with an incidence rate of 1.7/million per year in Europe. Histological classification is based on rate of non-malignant-appearing thymic epithelial cells and proportions of lymphocytes (A, AB, B1, B2, B3, and C), while staging system concerns localisation of the involved ...
Scorsetti M +8 more
openaire +3 more sources
Gut microbiota–derived short‐chain fatty acids regulate group 3 innate lymphoid cells in HCC
Abstract Background and Aims Type 3 innate lymphoid cells (ILC3s) are essential for host defense against infection and tissue homeostasis. However, their role in the development of HCC has not been adequately confirmed. In this study, we investigated the immunomodulatory role of short‐chain fatty acids (SCFAs) derived from intestinal microbiota in ILC3
Chupeng Hu +11 more
wiley +1 more source
Background It is often difficult to distinguish between thymoma and thymic carcinoma by preoperative radiological tests. While there have been some reports that the maximum standardized uptake value (SUVmax) in positron emission tomography‐computed ...
Takashi Kanou +7 more
doaj +1 more source
Metronomics for thymic carcinoma [PDF]
Although thymomas are the most frequent primary tumours of the anterior mediastinum, thymic carcinoma is very infrequent and more aggressive. Combination chemotherapy is the first-line treatment for the advanced stages, but because of the lack of evidence from randomised trials, the management of the successive lines is a challenging field. We report a
del Toro, Jacobo Muñoz +4 more
openaire +2 more sources

